Paper40418878
5-HT2A receptors: Pharmacology and functional selectivity.
Cummins BR and 3 others. Pharmacol Rev, 2025. Cited by 69 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. 5-HT2A receptors: Pharmacology and functional selectivity. Papers, record 40418878. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40418878
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Receptor, Serotonin, 5-HT2A | Major topic |
| Serotonin 5-HT2 Receptor Agonists | Major topic |
| Humans | |
| Animals | |
| Hallucinogens | |
| Serotonin 5-HT2 Receptor Antagonists | |
| Mental Disorders |
Source PubMed
References109
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38,644,550 | Ligand bias and inverse agonism on 5-HT2A receptor-mediated modulation of G protein activity in post-mortem human brain. | Br J Pharmacol | 2025 | https://conductscience.org/library/papers/38644550 | PubMed |
| 2 | 30,639,101 | Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex. | Cell | 2019 | https://conductscience.org/library/papers/30639101 | PubMed |
| 3 | 35,106,752 | Community guidelines for GPCR ligand bias: IUPHAR review 32. | Br J Pharmacol | 2022 | https://conductscience.org/library/papers/35106752 | PubMed |
| 4 | 11,069,907 | The dynamin-dependent, arrestin-independent internalization of 5-hydroxytryptamine 2A (5-HT2A) serotonin receptors reveals differential sorting of arrestins and 5-HT2A receptors during endocytosis. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11069907 | PubMed |
| 5 | 20,198,576 | Association between the -1438A/G polymorphism of the serotonin 2A receptor gene and late-onset psoriasis in a Thai population. | Genet Mol Res | 2010 | https://conductscience.org/library/papers/20198576 | PubMed |
| 6 | 19,889,983 | Rapid modulation of spine morphology by the 5-HT2A serotonin receptor through kalirin-7 signaling. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19889983 | PubMed |
| 7 | 31,734,018 | Serotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: Selective biased agonism via Gαi1-proteins. | Eur Neuropsychopharmacol | 2019 | https://conductscience.org/library/papers/31734018 | PubMed |
| 8 | 6,483,122 | Selective 5HT-2 antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortex. | Neuropharmacology | 1984 | https://conductscience.org/library/papers/6483122 | PubMed |
| 9 | 27,909,165 | Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. | J Psychopharmacol | 2016 | https://conductscience.org/library/papers/27909165 | PubMed |
| 10 | 29,898,390 | Psychedelics Promote Structural and Functional Neural Plasticity. | Cell Rep | 2018 | https://conductscience.org/library/papers/29898390 | PubMed |
| 11 | 38,811,567 | G protein-specific mechanisms in the serotonin 5-HT2A receptor regulate psychosis-related effects and memory deficits. | Nat Commun | 2024 | https://conductscience.org/library/papers/38811567 | PubMed |
| 12 | 23,409,724 | 5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disorders. | Expert Opin Investig Drugs | 2013 | https://conductscience.org/library/papers/23409724 | PubMed |
| 13 | 31,073,061 | Structures of the M1 and M2 muscarinic acetylcholine receptor/G-protein complexes. | Science | 2019 | https://conductscience.org/library/papers/31073061 | PubMed |
| 14 | 20,926,677 | Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivo. | J Neurosci | 2010 | https://conductscience.org/library/papers/20926677 | PubMed |
| 15 | 24,567,306 | The evolution of the GPCR signaling system in eukaryotes: modularity, conservation, and the transition to metazoan multicellularity. | Genome Biol Evol | 2014 | https://conductscience.org/library/papers/24567306 | PubMed |
| 16 | 26,841,800 | Psychedelics. | Pharmacol Rev | 2016 | https://conductscience.org/library/papers/26841800 | PubMed |
| 17 | 17,000,863 | Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists. | Mol Pharmacol | 2006 | https://conductscience.org/library/papers/17000863 | PubMed |
| 18 | 31,243,364 | Conformational transitions of a neurotensin receptor 1-Gi1 complex. | Nature | 2019 | https://conductscience.org/library/papers/31243364 | PubMed |
| 19 | 36,099,411 | Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT2A Receptor Agonists. | J Med Chem | 2022 | https://conductscience.org/library/papers/36099411 | PubMed |
| 20 | 28,640,832 | Sarpogrelate hydrochloride ameliorates diabetic nephropathy associated with inhibition of macrophage activity and inflammatory reaction in db/db mice. | PLoS One | 2017 | https://conductscience.org/library/papers/28640832 | PubMed |
Cited by59
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,964,905 | Therapeutic Potential of Classical Psychedelics and Non-Hallucinogenic Psychoplastogens in Psychiatric Disorders. | Psychiatry Clin Psychopharmacol | 2026 | https://conductscience.org/library/papers/42964905 | PubMed |
| 42,881,224 | 5-HT2A receptors in layer 5 pyramidal neurons mediate the neuroplastic but not the hallucinogenic effects of psilocybin. | Nat Neurosci | 2026 | https://conductscience.org/library/papers/42881224 | PubMed |
| 42,774,867 | Targeting Serotonin 5-HT2A Receptors in the Treatment of Aggression: from Antipsychotics to Psychedelics. | Aggress Violent Behav | 2026 | https://conductscience.org/library/papers/42774867 | PubMed |
| 42,741,299 | Novel Tetrahydropyridinyl-6,6-Bicyclic Compounds as 5‑HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches. | ACS Med Chem Lett | 2026 | https://conductscience.org/library/papers/42741299 | PubMed |
| 42,709,856 | Deconstruction of lysergic acid diethylamide. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/42709856 | PubMed |
| 42,658,346 | The Potential of Cannabidiol for the Treatment of Psychosis: Endocannabinoid Regulation of Serotonergic Neurotransmission via Serotonin 5-HT1A/2A Receptors. | Neurochem Res | 2026 | https://conductscience.org/library/papers/42658346 | PubMed |
| 42,653,771 | Natural Products as GPCR-Targeting Antidepressant Candidates: Advances and Opportunities. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42653771 | PubMed |
| 42,645,703 | Next-Generation Pharmacotherapies for Unipolar Mood Disorders: A Leading Article on Phase II/III Drug Development Across Diverse Mechanisms. | CNS Drugs | 2026 | https://conductscience.org/library/papers/42645703 | PubMed |
| 42,643,666 | Exploring the toxicity of extracts, fractions, and their bioactive components from raw and roasted sea buckthorn seeds on selected human cells. | Front Mol Biosci | 2026 | https://conductscience.org/library/papers/42643666 | PubMed |
| 42,621,951 | Novel 6,5-Bicyclic Compounds as 5‑HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches. | ACS Med Chem Lett | 2026 | https://conductscience.org/library/papers/42621951 | PubMed |
| 42,621,425 | Novel Compounds as 5‑HT2A Agonists for Treating Mental Illness or CNS Disorders. | ACS Med Chem Lett | 2026 | https://conductscience.org/library/papers/42621425 | PubMed |
| 42,463,904 | Integrated 5-HT2A-TrkB and G protein signaling in serotonergic psychedelic responses. | Mol Psychiatry | 2026 | https://conductscience.org/library/papers/42463904 | PubMed |
| 42,445,008 | Novel 5,6-Bicyclic Compounds as 5‑HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches. | ACS Med Chem Lett | 2026 | https://conductscience.org/library/papers/42445008 | PubMed |
| 42,432,011 | Epigenetic landscapes of classical psychedelics and ketamine: molecular mechanisms of long-lasting neuromodulation. | Mol Psychiatry | 2026 | https://conductscience.org/library/papers/42432011 | PubMed |
| 42,305,206 | Novel Tricyclic Compounds as 5‑HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches. | ACS Med Chem Lett | 2026 | https://conductscience.org/library/papers/42305206 | PubMed |
| 42,257,400 | Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics. | ACS Chem Neurosci | 2026 | https://conductscience.org/library/papers/42257400 | PubMed |
| 42,212,869 | A systematic review of the pharmacokinetics of classical serotonergic psychedelic compounds in healthy adult subjects. | J Psychopharmacol | 2026 | https://conductscience.org/library/papers/42212869 | PubMed |
| 42,157,830 | Novel Indoline Derivatives Serotonergic Psychedelic Agents as 5‑HT2A Agonists for Treating Psychosis, Mental Illness and CNS Disorders. | ACS Med Chem Lett | 2026 | https://conductscience.org/library/papers/42157830 | PubMed |
| 42,084,443 | Developmental and cell type-specific contributions of thalamic serotonin 2A receptors to absence seizures. | Epilepsia | 2026 | https://conductscience.org/library/papers/42084443 | PubMed |
| 41,993,281 | Dissociating the Hallucinogenic and Neuroplastic Effects of Psilocybin. | bioRxiv | 2026 | https://conductscience.org/library/papers/41993281 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40418878
GET https://conductscience.org/api/papers/v1/40418878/references?page=2